The newly rebranded Association for Accessible Medicines (AAM) recently launched a nationwide campaign with the mission of 'Keeping Medicines in Reach,' sharing patient profiles and maintaining its vision to control existing drug costs. Read More »
The listed price for brand-name drugs increased 11 percent last year, but the largest pharmacy benefits manager in the U.S. said it shielded employers it works with from the bulk of that increase. Read More »
The sPCMA Business Forum will be held March 8-9, providing valuable information into specialty drug benefit management, specialty pharmacies, drug manufacturers and related topics. Read More »
Eli Lilly & Co. has updated the label of Trulicity, a drug used to help control Type 2 diabetes, to state that the drug may be used in combination with insulin. Read More »
i-Health Inc. is moving toward the acquisition of UP4 Probiotics from UAS Laboratories LLC in an arrangement the company believes will help it become a leader in the probiotic world. Read More »
The recent National Association of Chain Drug Stores Regional Chain Conference in Palm Beach, Florida addressed the important role of pharmacies in this country amid possible changes under President Donald Trump's administration. Read More »
Pfizer Inc. has partnered with relationship expert Logan Levkoff to host a Q&A session on relationship and intimacy advice for people dealing with chronic diseases. Read More »
ACADIA Pharmaceuticals was chosen to present at the 35th Annual J.P. Morgan Healthcare Conference this year. Read More »
Renova Therapeutics Inc. recently entered an alliance with Janssen Pharmaceuticals Inc. for the development of new treatments for congestive heart failure and Type 2 diabetes. Read More »
Five speakers to the Parenteral Drug Association Pharmaceutical Quality Metrics and Culture Conference have been named. Read More »
The National Association of Specialty Pharmacy recently made a new app available for members only. Read More »
The U.S. Food and Drug Administration has accepted Intarcia Therapeutics' New Drug Application for ITCA 650, which can be used to treat Type 2 diabetes. Read More »
Biotechnology company Acorda Therapeutics Inc., which is known for its work in neurological disorders, will present at two investor conferences this month. Read More »
President Trump recently met with pharmaceutical executives concerning the prices of drugs and the regulations surrounding them. Read More »
Digital Pharmacist Inc. was launched Jan. 31 after the strategic merger of TeleManager Technologies Inc. and RxWiki Inc. Read More »
Blue Shield of California and OptumRX will co-sponsor agricultural trade organization UnitedAg's 37th Annual Meeting and Conference in Napa, California, March 14-17. Read More »
Access to affordable and dependable health care for women has become growing issue, and one facility says that it is prepared to play a big role in the solution in making women’s health care more accessible. Read More »
Systech International's Serialized by November program helped numerous manufacturers comply with the standards outlined in the Drug Supply Chain Security Act before its deadline. Read More »
DePuy Synthes and Pacira Pharmaceuticals have entered into a partnership to promote pain reliever Exparel. Read More »
Johnson & Johnson has bought the controlling shares of Switzerland-based Actelion, with an immediate finalization of the transaction. Read More »
Alerts Sign-up
